Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the ALBUTEROL SULFATE 51022-70-9 CAS number simply 188062-50-2, is a crucial drug utilized in the treatment of HIV disease . Its mechanism of action involves inhibiting reverse enzymes, a vital protein for viral copying. Patients receiving this medication must undergo genetic examination prior to commencement, due to a risk of hypersensitivity reaction linked to the HLA-B*57:01 allele. This adverse effect can range from mild skin irritation to a severe, life-threatening syndrome . Careful assessment and patient education are therefore essential for safe and effective utilization of abacavir compound.

Abarelix: Exploring Compound 183552-38-7

Abarelix, identified as compound 183552-38-7, is a artificially-produced decapeptide designed for the management of enlarged prostate. This compound functions as a selective gonadotropin-releasing hormone (GnRH) blocker , effectively suppressing testosterone production. Research into the molecule has focused on its ability to alleviate associated conditions and potentially provide an alternative to conventional interventions. The structural profile of 183552-38-7 is intricate, showcasing a distinct amino acid sequence resulting in its particular mechanism of action . Additional clinical research are ongoing to completely evaluate its extended security and effectiveness .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone salt is an copyrightal inhibitor of CYP17A1, an enzyme crucial for male hormone biosynthesis. Its chemical formula is C26H30O3, and it’s frequently identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing unique identifier for accurate identification. The medication 's properties include significant affinity for CYP17A1, resulting in lower androgen concentrations and exhibiting certain white to off-white solid appearance. Further analysis using analytical approaches is typically conducted to establish identity and consistency.

CAS Number Spotlight: Abacavir Sulfate – 188062-50-2 CAS

This piece focuses on a significant pharmaceutical compound : Abacavir Sulfate Salt , identified by its unique Chemical Abstracts Service (CAS) designation: 188062-50-2. This agent is a vital part in the treatment of the HIV infection, frequently prescribed in along with other antiretroviral therapies . Knowing this identification number is useful for professionals in the pharmaceutical sector .

Key points regarding Abacavir Sulfate :

  • Purpose: Works as a nucleoside reverse transcriptase suppressor.
  • Utility: Generally used in AIDS management.
  • Identification : The CAS identifier 188062-50-2 offers accurate labeling .

Investigating Abarelix: Structural Profile (183552-38-7)

Abarelix, identified by the unique designation 183552-38-7, represents a fascinating example within the realm of decapeptide study. Its complex arrangement is crucial to its pharmacological function. Broadly, this molecule is a synthetic decapeptide, designed to target and inhibit gonadotropin-releasing GnRH. The chemical formula reveals a sequence of amino acids carefully positioned to obtain a specific interaction with the GnRH site.

  • Additional research are conducted to fully determine its pathway of impact.
  • Understanding its creation is vital for increasing manufacture.
  • The specific sequence dictates its efficacy.

Abiraterone Compound (154229-18-2): Uses and Molecular Profile

{Abiraterone Acetate , with the CAS number 154229-18-2, is a drug primarily indicated in the treatment of metastatic male tumor, specifically those containing mutations in the phosphatase tensin pathway. It functions as an blocker of 3β-hydroxycopyright P450c17, an enzyme responsible for androgen production . Chemically, it’s a synthetic hormone with a complex design , designed to effectively diminish androgen levels. Its therapeutic application has significantly improved outcomes for patients with late-stage prostate malignancy.

Leave a Reply

Your email address will not be published. Required fields are marked *